Jones Rupert, Kirenga Bruce J, Katagira Wincelsas, Singh Sally J, Pooler Jill, Okwera Alphonse, Kasiita Richard, Enki Doyo G, Creanor Siobhan, Barton Andy
Population Studies and Clinical Trials, Peninsula Schools of Medicine and Dentistry, Plymouth University, Plymouth, UK.
Population Studies and Clinical Trials, Makerere Lung Institute, Makerere University College of Health Sciences, Mulago Hospital, Kampala, Uganda.
Int J Chron Obstruct Pulmon Dis. 2017 Dec 11;12:3533-3539. doi: 10.2147/COPD.S146659. eCollection 2017.
SETTING: The study was conducted at Mulago Hospital, Kampala, Uganda. OBJECTIVE: As chronic respiratory disease (CRD) is a huge, growing burden in Africa, with few available treatments, we aimed to design and evaluate a culturally appropriate pulmonary rehabilitation (PR) program in Uganda for people with post-tuberculosis lung disorder (p-TBLD). DESIGN: In a pre-post intervention study, a 6-week, twice-weekly PR program was designed for people with p-TBLD. Outcome measures included recruitment, retention, the Clinical COPD Questionnaire (CCQ), tests of exercise capacity, and biometrics. Given this was a developmental study, no formal statistical significance testing was undertaken. RESULTS: In all, 34 participants started PR and 29 (85%) completed all data collection. The mean age of the 29 participants was 45 years, and 52% were female. The mean (95% confidence interval) CCQ score at baseline was 1.8 (1.5, 2.0), at the end of PR was 1.0 (0.8, 1.2), and at 6 weeks after the end of PR was 0.8 (0.7, 1.0). The Incremental Shuttle Walking Test (ISWT) was 299 m (268.5, 329.4) at baseline, 377 (339.6, 413.8) at the end of PR, and 374 (334.2, 413.5) at 6 weeks after the end of PR. Improvements were seen in measures of chest pain; 13/29 (45%) participants reported chest pain at baseline but only 7/29 (24%) at the end of PR, and in those with persistent pain, the mean pain scores decreased. Mild hemoptysis was reported in 4/29 (17%) participants at baseline and in 2/29 (7%) at the end of PR. CONCLUSION: PR for people with p-TBLD in Uganda was feasible and associated with clinically important improvements in quality of life, exercise capacity, and respiratory outcomes. PR uses local resources, requires little investment, and offers a new, sustainable therapy for p-TBLD in resource-limited settings. With the rising global burden of CRD, further studies are needed to assess the value of PR in p-TBLD and other prevalent forms of CRD.
Int J Chron Obstruct Pulmon Dis. 2017-12-11
Int J Chron Obstruct Pulmon Dis. 2018-8-8
Int J Chron Obstruct Pulmon Dis. 2016-8-25
Int J Chron Obstruct Pulmon Dis. 2025-1-31
Int J Chron Obstruct Pulmon Dis. 2017-11-8
Int J Chron Obstruct Pulmon Dis. 2008
IJTLD Open. 2025-7-9
Public Health Action. 2025-6-4
IJTLD Open. 2024-11-1
EClinicalMedicine. 2024-5-27
EClinicalMedicine. 2024-2-26
PLOS Glob Public Health. 2024-1-29
Int J Tuberc Lung Dis. 2016-8
Cochrane Database Syst Rev. 2015-2-23
Am J Respir Crit Care Med. 2013-10-15
Prim Care Respir J. 2011-9
BMC Public Health. 2010-5-19